Literature DB >> 24212502

The emerging role of TH17 cells in organ transplantation.

Jeremy A Sullivan1, Andrew B Adams, William J Burlingham.   

Abstract

While transplantation research continues to focus on the development of Treg-sparing and plasma cell/B-cell-targeting strategies to improve long-term outcomes, little attention has been paid to the emerging role of the TH17 cell in mediating chronic rejection. This review aimed to summarize the recent emergence of the TH17 and the newly described TH1/17 cell as major players in transplantation and to suggest ways of improving graft outcome through TH17-targeted immunosuppression.

Entities:  

Mesh：

Year:  2014        PMID： 24212502     DOI： 10.1097/TP.0000000000000000

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


  13 in total

1.  Cutting Edge: Allograft Rejection Is Associated with Weak T Cell Responses to Many Different Graft Leukocyte-Derived Peptides.

Authors:  Adam L Burrack; Deepali Malhotra; Thamotharampillai Dileepan; Kevin C Osum; Linnea A Swanson; Brian T Fife; Marc K Jenkins
Journal:  J Immunol       Date:  2017-12-18       Impact factor: 5.422

2.  Hyperlipidemia Promotes Anti-Donor Th17 Responses That Accelerate Allograft Rejection.

Authors:  J Yuan; J Bagley; J Iacomini
Journal:  Am J Transplant       Date:  2015-06-16       Impact factor: 8.086

3.  Treg-Cell-Derived IL-35-Coated Extracellular Vesicles Promote Infectious Tolerance.

Authors:  Jeremy A Sullivan; Yusuke Tomita; Ewa Jankowska-Gan; Diego A Lema; Matt P Arvedson; Ashita Nair; William Bracamonte-Baran; Ying Zhou; Kristy K Meyer; Weixiong Zhong; Deepali V Sawant; Andrea L Szymczak-Workman; Qianxia Zhang; Creg J Workman; Seungpyo Hong; Dario A A Vignali; William J Burlingham
Journal:  Cell Rep       Date:  2020-01-28       Impact factor: 9.423

4.  Th17 Responses to Collagen Type V, kα1-Tubulin, and Vimentin Are Present Early in Human Development and Persist Throughout Life.

Authors:  J A Sullivan; E Jankowska-Gan; S Hegde; M A Pestrak; V V Agashe; A C Park; M E Brown; J F Kernien; D S Wilkes; D B Kaufman; D S Greenspan; W J Burlingham
Journal:  Am J Transplant       Date:  2016-12-19       Impact factor: 8.086

5.  Complement Blockade in Recipients Prevents Delayed Graft Function and Delays Antibody-mediated Rejection in a Nonhuman Primate Model of Kidney Transplantation.

Authors:  Michael J Eerhart; Jose A Reyes; Casi L Blanton; Juan S Danobeitia; Peter J Chlebeck; Laura J Zitur; Megan Springer; Erzsebet Polyak; Jennifer Coonen; Saverio Capuano; Anthony M D'Alessandro; Jose Torrealba; Edwin van Amersfoort; Yolanda Ponstein; Cees van Kooten; William Burlingham; Jeremy Sullivan; Myron Pozniak; Weixiong Zhong; Yucel Yankol; Luis A Fernandez
Journal:  Transplantation       Date:  2022-01-01       Impact factor: 5.385

6.  P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes.

Authors:  Francesca D'Addio; Andrea Vergani; Luciano Potena; Anna Maestroni; Vera Usuelli; Moufida Ben Nasr; Roberto Bassi; Sara Tezza; Sergio Dellepiane; Basset El Essawy; Maria Iascone; Attilio Iacovoni; Laura Borgese; Kaifeng Liu; Gary Visner; Sirano Dhe-Paganon; Domenico Corradi; Reza Abdi; Randall C Starling; Franco Folli; Gian Vincenzo Zuccotti; Mohamed H Sayegh; Peter S Heeger; Anil Chandraker; Francesco Grigioni; Paolo Fiorina
Journal:  J Clin Invest       Date:  2018-07-16       Impact factor: 14.808

7.  Regulation of human T cell responses by dNP2-ctCTLA-4 inhibits human skin and microvessel graft rejection.

Authors:  Sangho Lim; Nancy C Kirkiles-Smith; Jordan S Pober; Alfred L M Bothwell; Je-Min Choi
Journal:  Biomaterials       Date:  2018-08-21       Impact factor: 12.479

8.  The c.503T>C Polymorphism in the Human KLRB1 Gene Alters Ligand Binding and Inhibitory Potential of CD161 Molecules.

Authors:  Sascha Rother; Joachim Hundrieser; Claudia Pokoyski; Sonja Kollrich; Katja Borns; Rainer Blasczyk; Daniel Poehnert; Jürgen Klempnauer; Reinhard Schwinzer
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

Review 9.  Transplantation Tolerance Induction: Cell Therapies and Their Mechanisms.

Authors:  Joseph R Scalea; Yusuke Tomita; Christopher R Lindholm; William Burlingham
Journal:  Front Immunol       Date:  2016-03-07       Impact factor: 7.561

10.  Epitope analysis of the collagen type V-specific T cell response in lung transplantation reveals an HLA-DRB1*15 bias in both recipient and donor.

Authors:  Melissa R Keller; Lynn D Haynes; Ewa Jankowska-Gan; Jeremy A Sullivan; Vrushali V Agashe; Scott R Burlingham; William J Burlingham
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.